Home Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor
Article
Licensed
Unlicensed Requires Authentication

Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor

  • Adam Suleman ORCID logo , D. William Cameron , Vicente Corrales-Medina , Christopher McCudden and Juthaporn Cowan ORCID logo EMAIL logo
Published/Copyright: November 19, 2020

Abstract

Objectives

The value of the serum protein gap (PG, difference between total protein and albumin) in the detection of hyper- or hypogammaglobulinemia is not well established. We assessed the performance of PG for the detection of hyper- or hypogammaglobulinemia in a large sample of patients.

Methods

We reviewed all paired measurements of serum total protein, albumin, quantitative immunoglobulins, and serum protein electrophoresis tested between March 2014 and June 2017 at the Eastern Ontario Regional Laboratory Association. Sensitivity, specificity, positive predictive value, negative predictive value and likelihood ratios of PG at thresholds between 18 and 44 g/L for the detection of hyper- and hypogammaglobulinemia were assessed.

Results

There were 19,575 and 5,426 simultaneous paired data points to assess hyper- and hypogammaglobulinemia identified by serum protein electrophoresis (SPE) and nephelometry, respectively. The mean PG was 36.3 g/L (SD 8.6). The prevalence of hypergammaglobulinemia (>16 g/L by SPE) and hypogammaglobulinemia (IgG <7 g/L) was 21.9 and 5.5%, respectively. High PG (≥38 g/L) had sensitivity and specificity of 76.2 and 71.5% respectively for hypergammaglobulinemia. PG ≥38 g/L had a negative predictive value (NPV) of 93.1% for monoclonal, and 96.9% for polyclonal gammopathy. A PG threshold of ≤18 g/L had of sensitivity of 0.4%, specificity of 100%, PPV of 100% and NPV of 80.1% to detect hypogammaglobulinemia (IgG <7 g/L).

Conclusions

High and low PG values were not sensitive in detecting hyper- or hypogammaglobulinemia, although negative predictive values were high for both. Performance of PG should be further evaluated prospectively in specific populations at risk of for abnormal IgG levels.


Corresponding author: Juthaporn Cowan, MD, PhD, FRCPC, Clinical Epidemiology Program, The Ottawa Hospital Research Institute, 501 Smyth Road, K1H-8L6 Ottawa, Canada; and Department of Medicine, Division of Infectious Diseases, University of Ottawa, 501 Smyth Road, K1H-8L6 Ottawa, Canada, Phone: 613-798-8899 x 79617, Fax: 613-737-8352, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The study was approved by the Ottawa Hospital Research Institute Research Ethics Board (under the protocol number 20170437-01H).

References

1. Jolles, S, Borrell, R, Zouwail, S, Heaps, A, Sharp, H, Moody, M, et al.. Calculated globulin (CG) as a screening test for antibody deficiency. Clin Exp Immunol 2014;177:671–8. https://doi.org/10.1111/cei.12369.Search in Google Scholar

2. Stohl, W, Kenol, B, Kelly, AJ, Correa, AA, Panush, RS. Elevated serum globulin gap as a highly reliable marker of elevated erythrocyte sedimentation rate in patients with systemic rheumatic diseases. Semin Arthritis Rheum 2019;49:485–92. https://doi.org/10.1016/j.semarthrit.2019.05.001.Search in Google Scholar

3. Doweiko, JP, Nompleggi, DJ. Reviews: role of albumin in human physiology and pathophysiology. J Parenter Enteral Nutr 1991;15:207–11. https://doi.org/10.1177/0148607191015002207.Search in Google Scholar

4. Vavricka, SR, Burri, E, Beglinger, C, Degen, L, Manz, M. Serum protein electrophoresis: an underused but very useful test. Digestion 2009;79:203–10. https://doi.org/10.1159/000212077.Search in Google Scholar

5. Dupuis, MM, Paul, B, Loitsch, G, Mathews, P, Feinberg, D, Barak, I, et al.. Gamma gap: a point-of-care test that correlates with disease burden and treatment response in multiple myeloma. JCO Oncol Pract 2020;16:e751–7. https://doi.org/10.1200/JOP.19.00517.Search in Google Scholar

6. Thakkinstian, A, Tran, H, Reeves, G, Murch, S, Attia, J. A clinical decision rule to aid ordering of serum and urine protein electrophoresis for case-finding of paraproteins in hospitalized inpatients. J Gen Intern Med 2008;23:1688–92. https://doi.org/10.1007/s11606-008-0712-z.Search in Google Scholar

7. Holding, S, Khan, S, Sewell, WAC, Jolles, S, Dore, PC. Using calculated globulin fraction to reduce diagnostic delay in primary and secondary hypogammaglobulinaemias: results of a demonstration project. Ann Clin Biochem 2015;52:319–26. https://doi.org/10.1177/0004563214545791.Search in Google Scholar

8. Pecoraro, A, Jolles, S, Crescenzi, L, Varricchi, G, Marone, G, Savoia, M, et al.. Validation of calculated globulin (CG) as a screening test for antibody deficiency in an Italian University Hospital [Internet]. Curr Pharmaceut Biotechnol 2018;19:728–33. Available from: https://www.eurekaselect.com/164507/article [Cited 19 Jul 2020].10.2174/1389201019666180808163311Search in Google Scholar

9. Phelps, MA, Levitt, MA. Pretest probability estimates: a pitfall to the clinical utility of evidence‐based medicine? Acad Emerg Med 2004;11:692–4. https://doi.org/10.1197/j.aem.2003.08.022.Search in Google Scholar

10. IBM Corp. IBM SPSS statistics for Windows, version 24.0. Armonk, NY: IBM Corp.; 2016.Search in Google Scholar

11. Rajkumar, SV, Dimopoulos, MA, Palumbo, A, Blade, J, Merlini, G, Mateos, MV, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014;15:e538–48. https://doi.org/10.1016/s1470-2045(14)70442-5.Search in Google Scholar

12. Dispenzieri, A, Gertz, MA, Therneau, TM, Kyle, RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc 2001;76:476–87. https://doi.org/10.4065/76.5.476.Search in Google Scholar PubMed

13. Yang, M, Xie, L, Liu, X, Hao, Q, Jiang, J, Dong, B. The gamma gap predicts 4-year all-cause mortality among nonagenarians and centenarians. Sci Rep 2018;8:1046. https://doi.org/10.1038/s41598-018-19534-4.Search in Google Scholar PubMed PubMed Central

14. Tannou, T, Koeberle, S, Manckoundia, P, Aubry, R. Multifactorial immunodeficiency in frail elderly patients: contributing factors and management. Médecine Mal Infect 2019;49:167–72. https://doi.org/10.1016/j.medmal.2019.01.012.Search in Google Scholar PubMed

15. Cowan, J, Do, TL, Desjardins, S, Ramotar, K, Corrales-Medina, V, Cameron, DW. Prevalence of hypogammaglobulinemia in adult invasive pneumococcal disease. Clin Infect Dis 2018;66:564–9. https://doi.org/10.1093/cid/cix836.Search in Google Scholar PubMed

16. Wadhera, RK, Rajkumar, SV. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc 2010;85:933–42. https://doi.org/10.4065/mcp.2010.0337.Search in Google Scholar PubMed PubMed Central


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2020-1286).


Received: 2020-08-23
Accepted: 2020-10-29
Published Online: 2020-11-19
Published in Print: 2021-04-27

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Home pregnancy tests: quality first
  4. Review
  5. Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders
  6. Opinion Papers
  7. Basophil counting in hematology analyzers: time to discontinue?
  8. The role of laboratory hematology between technology and professionalism: the paradigm of basophil counting
  9. Recommendations for validation testing of home pregnancy tests (HPTs) in Europe
  10. General Clinical Chemistry and Laboratory Medicine
  11. The use of preanalytical quality indicators: a Turkish preliminary survey study
  12. The Italian External Quality Assessment (EQA) program on urinary sediment by microscopy examination: a 20 years journey
  13. Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LDL-C estimation
  14. Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor
  15. Impact of routine S100B protein assay on CT scan use in children with mild traumatic brain injury
  16. Using machine learning to develop an autoverification system in a clinical biochemistry laboratory
  17. Effect of collection matrix, platelet depletion, and storage conditions on plasma extracellular vesicles and extracellular vesicle-associated miRNAs measurements
  18. Pneumatic tube transportation of urine samples
  19. Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine
  20. A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane–tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies
  21. Immunosuppressant quantification in intravenous microdialysate – towards novel quasi-continuous therapeutic drug monitoring in transplanted patients
  22. Reference Values and Biological Variations
  23. Reference intervals for venous blood gas measurement in adults
  24. Cardiovascular Diseases
  25. Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy
  26. Diabetes
  27. Evaluation of the ARKRAY HA-8190V instrument for HbA1c
  28. Infectious Diseases
  29. An original multiplex method to assess five different SARS-CoV-2 antibodies
  30. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs
  31. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR
  32. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study
  33. Corrigenda
  34. Corrigendum to: Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
  35. Corrigendum to: Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents
  36. Letters to the Editor
  37. A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers
  38. Letter in reply to the letter to the editor of Harte JV and Mykytiv V with the title “A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data”
  39. SARS-CoV-2 serologic tests: do not forget the good laboratory practice
  40. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients
  41. Self-sampling at home using volumetric absorptive microsampling: coupling analytical evaluation to volunteers’ perception in the context of a large scale study
  42. Vortex mixing to alleviate pseudothrombocytopenia in a blood specimen with platelet satellitism and platelet clumps
  43. Comparative evaluation of the fully automated HemosIL® AcuStar ADAMTS13 activity assay vs. ELISA: possible interference by autoantibodies different from anti ADAMTS-13
  44. Significant interference on specific point-of-care glucose measurements due to high dose of intravenous vitamin C therapy in critically ill patients
  45. As time goes by, on that you can rely preservation of urine samples for morphological analysis of erythrocytes and casts
  46. Stability of control materials for α-thalassemia immunochromatographic strip test
  47. Reformulated Architect® cyclosporine CMIA assay: improved imprecision, worse comparability between methods
  48. Urine-to-plasma contamination mimicking acute kidney injury: small drops with major consequences
  49. Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism
  50. Use of common reference intervals does not necessarily allow inter-method numerical result trending
  51. Reply to Dr Hawkins regarding comparability of results for monitoring
Downloaded on 3.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2020-1286/html?srsltid=AfmBOooG1JMdRLFCkOHtUeb9a1KruDvGmqBqjI2UbLiVqBe7S_mTOGKY
Scroll to top button